Folgen
Douglas G Altman
Douglas G Altman
Centre for Statistics in Medicine, University of Oxford
Bestätigte E-Mail-Adresse bei csm.ox.ac.uk
Titel
Zitiert von
Zitiert von
Jahr
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
D Moher, A Liberati, J Tetzlaff, DG Altman, t PRISMA Group*
Annals of internal medicine 151 (4), 264-269, 2009
178691*2009
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
D Moher, A Liberati, J Tetzlaff, DG Altman, t PRISMA Group*
Annals of internal medicine 151 (4), 264-269, 2009
1461262009
Statistical methods for assessing agreement between two methods of clinical measurement
JM Bland, DG Altman
The lancet 327 (8476), 307-310, 1986
578831986
Statistical methods for assessing agreement between two methods of clinical measurements
JM Blaud, DG Altman
Lancet 12, 307-310, 1986
578781986
Measuring inconsistency in meta-analyses
JPT Higgins, SG Thompson, JJ Deeks, DG Altman
Bmj 327 (7414), 557-560, 2003
564532003
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
E Von Elm, DG Altman, M Egger, SJ Pocock, PC Gøtzsche, ...
The lancet 370 (9596), 1453-1457, 2007
54765*2007
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
A Liberati, DG Altman, J Tetzlaff, C Mulrow, PC Gøtzsche, JPA Ioannidis, ...
Annals of internal medicine 151 (4), W-65-W-94, 2009
536552009
The Cochrane Collaboration’s Tool for Assessing Risk of Bias in Randomised Trials
JP Higgins
The Cochrane Collaboration, 2011
309522011
Heart disease and stroke statistics—2017 update: a report from the American Heart Association
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ...
circulation 135 (10), e146-e603, 2017
264892017
Practical statistics for medical research
DG Altman
Chapman and Hall/CRC, 1990
263101990
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
JAC Sterne, MA Hernán, BC Reeves, J Savović, ND Berkman, ...
bmj 355, 2016
134022016
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies
PF Whiting, AWS Rutjes, ME Westwood, S Mallett, JJ Deeks, JB Reitsma, ...
Annals of internal medicine 155 (8), 529-536, 2011
124152011
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration
JP Vandenbroucke, E Elm, DG Altman, PC Gøtzsche, CD Mulrow, ...
Annals of internal medicine 147 (8), W-163-W-194, 2007
111232007
Measuring agreement in method comparison studies
JM Bland, DG Altman
Statistical methods in medical research 8 (2), 135-160, 1999
105231999
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials
D Moher, KF Schulz, DG Altman
The lancet 357 (9263), 1191-1194, 2001
101002001
Statistics notes: Cronbach's alpha
JM Bland, DG Altman
Bmj 314 (7080), 572, 1997
9138*1997
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD) the TRIPOD statement
GS Collins, JB Reitsma, DG Altman, KGM Moons
Circulation 131 (2), 211-219, 2015
89992015
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
TC Hoffmann, PP Glasziou, I Boutron, R Milne, R Perera, D Moher, ...
Bmj 348, 2014
83832014
Analysing data and undertaking meta‐analyses
JJ Deeks, JPT Higgins, DG Altman, Cochrane Statistical Methods Group
Cochrane handbook for systematic reviews of interventions, 241-284, 2019
8090*2019
Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research
C Kilkenny, WJ Browne, IC Cuthill, M Emerson, DG Altman
Journal of Pharmacology and Pharmacotherapeutics 1 (2), 94-99, 2010
78892010
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20